HappeningToo topic
Infliximab-dyyb reports
Browse community reports connected to Infliximab-dyyb. These reports can show that other people are describing similar experiences, but they do not prove that Infliximab-dyyb caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
35 problems
Abdominal Discomfort while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and abdominal discomfort appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and abdominal distension appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and abdominal pain upper appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and abdominal pain appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and anxiety appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and back pain appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chest Discomfort while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and chest discomfort appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and chills appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and constipation appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and cough appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and decreased appetite appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and diarrhea appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and dizziness appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and fatigue appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and feeling abnormal appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flushing while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and flushing appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and headache appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Heart Rate Increased while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and heart rate increased appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and hives appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and insomnia appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and itching appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and malaise appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Migraine while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and migraine appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and muscle spasms appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and myalgia appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and nausea appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and oropharyngeal pain appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and pain appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and rash appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and shortness of breath appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and skin redness appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and vomiting appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and weakness appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and weight decreased appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Infliximab-dyyb
FDA FAERS contains adverse-event reports in which Infliximab-dyyb and weight increased appear together. This does not establish that Infliximab-dyyb caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →